Last --
Change Today 0.00 / 0.00%
Volume 0.0
2503 On Other Exchanges
Symbol
Exchange
2503 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Nobuo Hanai Ph.D.

President of Kyowa Hakko Kirin Co, Kirin Holdings Company, Limited
AgeTotal Calculated CompensationThis person is connected to 10 board members in 1 different organizations across 3 different industries.

See Board Relationships
61--

Background*

Dr. Nobuo Hanai, Ph.D. has been the Chief Executive Officer and President of Kyowa Hakko Kirin Co., Ltd. since March 22, 2012. Dr. Hanai served as Senior Executive Managing Officer, Vice President, Head of Development Division and Managing Officer at Kyowa Hakko Kirin Co., Ltd. and also served as its Managing Director since March 22, 2012 and Executive Managing Officer since April 2009. He served as President and Chief Executive Officer of BioWa, Inc., subsidiary of ...

Read Full Background

Corporate Headquarters*

10-1 Shinkawa 2-chome
Tokyo, -- 104-8288

Japan

Phone: 81 3 5541 5321
Fax: --

Board Members Memberships*

2012-Present
Chief Executive Officer, President and Representative Director

Education*

Bachelor's Degree
Tokyo University of Science
Master's Degree
Waseda Business School
Doctorate
Yamaguchi University Graduate School of Medicine
Master's Degree
Fred Hutchinson Cancer Research Center, Education Centre

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
2503:JP ¥1,590.00 JPY +14.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Luther C. Kissam IVChief Executive Officer, President and Director
Albemarle Corporation
$800.0K
Clay B. Siegall Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Seattle Genetics Inc.
$724.4K
Simon E. Moroney Ph.D.Chairman of Management Board and Chief Executive Officer
Morphosys AG
€772.6K
Jan G. J. van de Winkel Ph.D.Co-Founder, Chief Executive Officer and President
Genmab A/S
kr10.7M
Michael L. Babich Chief Executive Officer, President and Director
INSYS Therapeutics, Inc.
$1.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KIRIN HOLDINGS CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.